Gastric acid exerts a feedback inhibition on the secretion of gastrin from antral G cells. This study examines whether gastrin gene expression is also regulated by changes in gastric pH. Achlorhydria was induced in rats by the gastric H+/K+ ATPase inhibitor, omeprazole (100 gmol/kg). This resulted in fourfold increases in both serum gastrin (within 2 h) and gastrin mRNA levels (after 24 h).
modulates somatostatin secretion and synthesis to mediate a paracrine inhibition on gastrin gene expression in adjacent G cells. Introduction Secretion of gastrin is inhibited by gastric acid, and this serves as a negative feed back control that prevents excess acid secretion (1) . Achlorhydria, as is seen in atrophic gastritis, releases antral gastrin cells (G cells) from this inhibition and consequently causes marked hypergastrinemia and G-cell hyperplasia (1) (2) (3) . Surgical ablation of gastric acid secretion in rats by fundectomy produces similar changes (4) and has also been shown to stimulate gastrin synthesis (5) . Chronic blockade of acid secretion with the H+/K+ ATPase antagonist omeprozole results in hypergastrinemia and, with prolonged treatment, in G-cell hyperplasia (6) (7) (8) . These results suggest that achlorhydria may also stimulate gastrin gene expression in G cells. Rapidly inducing achlorhydria with omeprazole allows this question to be addressed without the complication of G cell hyperplasia and should, therefore, illuminate the physiological mechanisms that regulate gastrin gene expression.
Substantial evidence supports the hypothesis that gastric acid inhibits gastrin secretion through somatostatin released from antral D cells (9, 10) . Somatostatin is a potent inhibitor of gastrin release (11) . Antral D cells have characteristic cytoplasmic projections onto G cells (12, 13) that may act as a pathway for paracrine inhibition by somatostatin. Since gastric acid stimulates somatostatin release (14) (15) (16) , gastrin secretion is thought to be inhibited by somatostatin released locally from these cytoplasmic processes. The inhibition ofgastrin secretion by antral somatostatin thus represents a probable example of paracrine regulation. Measurement ofchanges in somatostatin mRNA levels with changes in gastric pH may be of value in evaluating the D cell's role as a paracrine regulator of antral G cells, since these mRNA levels directly reflect D cell activity.
Although somatostatin's inhibitory action on gastrin secretion is well established, it is not known whether somatostatin also inhibits gastrin gene expression. In the pituitary, where somatostatin also mediates a similar feedback cycle involving the inhibition of hormone secretion (17), short term incubation with somatostatin does not inhibit growth hormone gene transcription (18) . This suggests a dissociation between somatostatin's ability to inhibit pituitary hormone secretion and its effects on hormone synthesis. Consequently, somatostatin may not necessarily inhibit gastrin gene expression despite its well described effects on gastrin secretion.
Methods
Omeprazole treatment. Male Sprague-Dawley rats weighing 180-220 g were fed regular laboratory chow ad lib. Omeprazole dissolved in 100 ,gmol/kg PEG 2000 (concentration 20 mg/ml) was injected intraperitoneally twice daily at 12-h intervals (0.2 ml PEG in 1 ml 0.15% NaHCO3). Control rats received intraperitoneal injections of 0.2 mls PEG alone in 1 ml NaHCO3. After an overnight fast, rats were anesthetized with ether, 1.5 ml of their blood was drawn by cardiac puncture, and then they were killed. The antrum was excised, and a similar weight of corpus from the greater curvature adjacent to the saccuscorpus margin was excised. The duodenum, excluding a 2-mm rim adjacent to the pylorus, was also removed. Tissues were immediately placed in guanidium thiocyanate lysis buffer (18) and homogenized using a polytron (Brinkmann Instruments Co., Westbury, NY).
RNA preparation. RNA was prepared by the lithium chloride precipitation method of Cathala et al. (19) and the concentration of RNA was measured spectrophotometrically by the absorbance at 260 A. The efficiency of RNA recovery, determined by adding 3H-labeled SP6 sense gastrin cRNA, was between 80-85%.
RNA probe synthesis. 32P-labeled RNA probes were synthesized using SP6 RNA polymerase (20) transcribed from rat gastrin (21) and somatostatin (22) cDNA templates. Synthetic oligonucleotides complementary to rat actin mRNA (TGCTGCAGTCTAGAGGATCC-GAATTCG) and 18S subunit ribosomal RNA were end labeled with 32p y ATP using polynucleotide kinase (108 cpm/lg sp act).
internal correction for RNA loading variations, dot-blot filters were hybridized with a 32P-labeled synthetic oligonucleotide that is complementary to 18S ribosomal RNA. The baked filters were prehybridized at 430C for several hours in sealed plastic bags containing 5 ml of 5X standard saline citrate (SSC), 0.2% Ficoll, 0.2% polyvinyl pyrroline, 0.2% BSA, 50 mM sodium phosphate buffer, pH 7.0, 1% SDS, and 0.1% sodium pyrophosphate-sonicated salmon sperm DNA (100 ug/ml). The 32P-labeled probe was added (106 cpm/ml) and the mixture was hybridized at 550C for 15 h. Filters were then washed in 0.2X SSC, 1% SDS at 550C three times for 20 min each time. Filters were exposed to x-ray film (Kodak AR-IO) for 6 and 18 h. Exposed film was developed and fluorograms were quantitated by scanning with a laser densitometer (LKB Instruments, Inc., Gaithersburg, MD) using an area integrator. The ribosomal RNA probe was then melted off by heating blots at 950C in 0.1 X SSC for 15 min. The blots were then exposed overnight to confirm the melting of the probe. Dot blots were then rehybridized with 32P-labeled RNA SP6 probes that were complementary to rat gastrin or somatostatin mRNA. Prehybridization and hybridization were performed as above with the following exceptions: hybridization solution contained 50% formamide, and 0.1% SDS, prehybridization temperature was 450C, and hybridization temperature was 650C. After hybridizing for 15 h, filters were washed with 0. IX SSC and 0.1% SDS three times for 20 min each time. Filters were then exposed for 6 and 18 h at room temperature. Individual dots were then cut out and the radioactivity was determined by scintillation spectrometry. The autoradiograms were then quantitated by densitometric scanning.
Northern blot analysis. RNA samples were denatured, (24) then electrophoresed on 1.4% agarose formaldehyde gels (24, 25) and were then transferred to nitrocellulose filters (26) . After Northern transfer, the nitrocellulose filters were baked in a vacuum oven at 80°C for 2 h.
Blots were hybridized as above with 32P-labeled gastrin and somatostatin probes at 65°C for 16 h. Blots were washed in 0.2X SSC, 0.1% SDS at 65°C three times for 20 min each time.
Gastrin RIA. Gastrin was measured using rabbit antisera 2604 (1/100,000 dilution) raised against synthetic human heptodecapeptide gastrin (gastrin 17) (27) . Tyrosine monoiodinated human gastrin 17 tracer was used in all assays (28) Statistical analysis. Data were analyzed for significant differences using unpaired Students t test. Confidence levels were of P < 0.01.
Results
Male Sprague-Dawley rats were treated with omeprazole (100 ,gmol/kg) twice daily for 5 d, in parallel with matched controls that were injected with the PEG carrier alone. In both groups blood was drawn for gastrin RIA and RNA was isolated for mRNA determination. Treatment with omeprazole resulted in a marked hypergastrinemia (Fig. 1 A) , serum gastrin being fivefold higher in omeprazole-treated rats. Omeprazole treatment also increased gastrin mRNA levels as shown by Northern blot analysis ( Fig. 1 C) and dot-blot quantitation (Fig. 2 B) . Northern blot analysis of antral RNA ( Fig. 1 C) shows a single gastrin mRNA species (-570 nucleotides). The intensity of gastrin mRNA hybridization was increased in RNA from omeprazole-treated rats compared with control. Densitometric quantitation showed that omeprazole induced an increase in gastrin mRNA levels. Gastrin mRNA levels were 0.1 1±0.05 O.D. units for control RNA and 0.66±0.07 O.D. units for omeprazole-treated RNA, mean±SE, n = 10, P < 0.01. To determine whether the increase in gastrin mRNA induced by omeprazole was specific, actin mRNA levels were measured on the same blotted RNA samples (Fig. 1 B) . In contrast to gastrin mRNA, actin mRNA levels were not significantly increased in RNA from omeprazole-treated rats. Actin mRNA To measure more accurately the changes in gastrin mRNA levels with omeprazole treatment, antral RNA from 14 omeprazole-treated rats was quantitated by dot-blot analysis and compared with controls ( Fig. 2) . 10, 5, and 2.5 ,ug of total antral RNA was immobilized on nitrocellulose and hybridized to a gastrin cRNA probe. A representative autoradiogram is shown in Fig. 2 A. As a control for nonspecific hybridization of the RNA probe to ribosomal RNA, corpus RNA was also blotted and hybridized in the same filter. There was no significant binding of the gastrin probe to corpus RNA under the hybridization and washing conditions used (Fig. 2 A) . Hybridization of the gastrin probe to antral RNA samples was quantitated both by scanning autoradiograms with a soft laser densitometer (LKB Instruments) and by directly measuring the 32P radioactivity bound to the filters by Cherenkov counting in a liquid scintillation counter. Both methods gave nearly identical results for the increase in gastrin mRNA with omeprazole treatment. The amount of gastrin mRNA hybridized was directly proportional to the quantity of total RNA bound to the filter. At all quantities of bound RNA, gastrin mRNA levels were significantly greater in omeprazole-treated rats (-3.5-fold higher). To exclude a systematic difference in the binding of omeprazole and control RNA samples to the filters, a 32p_ labeled synthetic oligonucleotide that was complementary to the 1 8S subunit of ribosomal RNA was hybridized to the filters before hybridization with the gastrin probe. Fig. 2 C illustrates the autoradiogram of the 1 8S ribosomal probe hybridized to filters shown in Fig. 2 A. Hybridization was quantitated by scanning with a densitometer and plotted against the amount of RNA that was loaded. Ribosomal RNA bound quantitatively to the nitrocellulose and the levels of ribosomal RNA bound in omeprazole-treated samples was not greater than in control RNA samples. This implies that the concentration of gastrin mRNA transcripts is greater in omeprazole-treated rats.
This observed increase in gastrin mRNA could result from increases in the number of gastrin cells (G-cell hyperplasia) or omeprazole-treated rats was subjected to Northern blot analysis by hybridization with a rat somatostatin cRNA probe (Fig.  3 A) . A single mRNA species of 670 nucleotides was detected, which is consistent with previous observations (31) . The intensity of somatostatin hybridization to RNA from omeprazole-treated rats was lower than that of control RNA samples (Fig. 3 B) as quantitated by densitometric scanning. To determine whether the decrease in somatostatin mRNA was specific, actin mRNA levels on the same filters were also determined. The somatostatin mRNA levels for each sample were expressed as a ratio of the corresponding actin mRNA levels for each sample (Fig. 3 8) . The somatostatin mRNA to actin mRNA ratio was nearly threefold lower in RNA from omeprazole-treated rats compared with RNA from control-treated rats. The decreased somatostatin synthesis was also demonstrated by decreased somatostatin peptide concentration in antral extracts. (Fig. 3 C) . Dot-blot analysis was used to quantitate somatostatin mRNA levels more precisely (Fig. 4) trum, duodenal 'endocrine cells are not exposed to an acid environment, the pH of duodenal contents being maintained near neutrality by pancreatic bicarbonate secretion. Omeprazole-induced achlorhydria is therefore unlikely to have any effect on duodenal pH, since the reduced acidity of the gastric contents that empty into the duodenum are balanced by reduced secretin-mediated stimulation ofpancreatic bicarbonate secretion.
To determine the time course of the stimulation of gastrin secretion and synthesis induced by omeprazole, serum gastrin and gastrin mRNA levels were determined in rats treated with omeprazole for 1, 2, 4, and 12 h after a single intravenous injection or 12 h after 1-, 2-, or 5-d course of intraperitoneal injections given twice daily (8 a.m. and 5 p.m.). The levels of gastrin and somatostatin mRNA in antral RNA were quantitated by both Northern blot (Fig. 6 ) and dot-blot analyses (Fig.  7) . Although serum gastrin was elevated 2 h after a single injection of omeprazole, more than 24 h were required for a significant increase in gastrin mRNA levels (Figs. 6 and 7 B) . The decrease in somatostatin mRNA levels in the antrum was also delayed, occurring 24 h after omeprazole-induced achlorhydria (Figs. 6 B and 7 A). and gastrin (B) mRNA levels in antral mRNA with omeprazole-induced achlorhydria. Antral RNA was isolated from rats 4 and 12 h after an omeprazole injection (100l mol/ kg, i.v., bis die) and 1, 2, 3, and 5 d after omeprazole .l0O-ug, bis die intraperitoneal injection, and compared with * mRNA levels in untreated controls. mRNA levels were quantitated by dot-blot hybridization as described in Fig. 2 A and Fig. 4 B, respectively. Resuits are expressed as mean±SE, n = 4. *P < 0.01. If decreased somatostatin release causes the increased levels of gastrin mRNA seen with omeprazole-induced achlorhydria, then administration of an amount of exogenous somatostatin sufficient to increase local somatostatin levels should prevent the increase in gastrin mRNA. To test this hypothesis, omeprazole-treated and control rats were injected with the long-acting somatostatin analogue SMS 201-995 (10 ag/kg twice daily for 5 d) (32) . Antral RNA was isolated and gastrin mRNA levels were determined by Northern and quantitative dot-blot analysis. Exogenous somatostatin prevented both the increase in serum gastrin and gastrin mRNA that resulted from omeprazole treatment (Fig. 8) . Somatostatin injections, however, did not change serum-gastrin concentrations or gastrin mRNA levels in control rats. Furthermore, exogenous somatostatin did not prevent the decrease in antral somatostatin mRNA (Fig. 3 A, lanes 7 and 8) or peptide levels (Fig. 8 C) seen after omeprazole treatment. This excludes the trivial explanation for the inhibition ofgastrin gene expression by exogenous somatostatin after omeprazole treatment, namely that somatostatin prevents omeprazole-induced achlorhydria, an effect reported by de Graefet al. (33) .
Discussion
Although the regulation ofgastrin secretion is well understood (1), few studies have investigated the physiological factors that control gastrin gene expression. A previous study suggested that surgically induced achlorhydria stimulated gastrin biosynthesis and increased gastrin secretion as well (5) . The rapid and complete blockade of gastric acid secretion with omeprazole offers a convenient approach with which the effects of short term achlorhydria on gastrin gene expression can be demonstrated. Omeprazole-induced achlorhydria stimulates a specific increase in antral gastrin gene expression without any effect on duodenal gastrin mRNA levels. Although gastrin secretion is stimulated within 2 h ofan omeprazole injection, the (36) . Although reduced acidity increased venous gastrin, and increased acidity reduced gastrin levels, these were not coupled to reciprocal changes in somatostatin levels in venous blood. This suggests that gastric pH changes can alter gastrin secretion by pathways that do not necessarily involve somatostatin. The difficulty with this type ofstudy, however, is that venous somatostatin concentrations do not direptly measure paracrine release of somatostatin into the extracellular space. This is emphasized by the failure in this study to observe a difference between arterial and venous somatostatin concentration. It is questionable whether changes in paracring release with altered gastric pH could be measured in these patients.
In contrast to the above work, the present study suggests that even short-term achlorhydria induced by omeprazole stimulates gastrin secretion and gene expression through reduced somatostatin inhibition of G-cell activity. Omeprazole treatment causes a twofold decrease in somatostatin mRNA levels in the antral mucosa associated with the increase in gastrin mRNA levels. Uplike measuring changes in venous somatostatin levels, these somatostatin mRNA changes directly reflect decreased D-cell activity and imply that there is decreased synthesis and release of somatostatin with achlorhydria. Furthermore, in contrast to Koop et al. (35) , the omeprazole-induced decrease in somatostatin mRNA levels occurred at the same time as the increase in gastrin mRNA levels. More direct evidence that somatostatin regulates antral gastrin gene expression is provided by the observation in this study that exogenous somatostatin prevents the stimulation of gastrin mRNA levels by omeprazole.
Although this observed reduced somatostatin synthesis is consistent with reduced G-cell inhibition, the decreased somatostatin mRNA levels are only seen after the onset of the hypergastrinemia. However, the relationship between the onset of increased G-cell secretion and the fall in somatostatin mRNA levels is indirect. The proposed paracrine model postulates that achlorhydria results in both decreased somatostatin secretion and decreased somatostatin gene transcription. It is the kinetics of the decrease in somatostatin secretion that determines the time course of G-cell effects. The time course of somatostatin mRNA changes, on the other hand, is determined by both the decrease in transcription and the somatostatin mRNA half life. Like the mRNA that encodes other regulatory peptides, the half lives of gastrin and somatostatin mRNA are long. In gastrin-and somatostatin-expressing islet cell lines, actinomycin chase studies have shown that mRNA half lives are > 12 h (unpublished observations). Consequently, the decrease in somatostatin mRNA levels with omeprazole is not seen until after 24 h. Furthermore, the half lives of both somatostatin and gastrin mRNAs are independent variables; the time courses of the two mRNAs are only indirectly related to each other, even though the changes in gene transcription may occur at the same time.
This study, therefore, suggests that somatostatin specifically inhibits gastrin mRNA accumulation as well as gastrin secretion in antral G cells, by regulating either gastrin gene transcription or mRNA stability. In contrast to the inhibition of hormone secretion, effects of somatostatin on gene expression have not been well described. Baringa et al. (18) , however, reported that somatostatin does not inhibit growth hormone gene transcription stimulated by growth hormone-releasing factor even though somatostatin inhibited both growth hormone secretion and the rise in cAMP which was shown to stimulate growth hormone gene transcription. This suggests that the inhibitory effects ofsomatostatin on secretion may not necessarily be linked to its effects on gene transcription. There are many differences between the present study and Baringa et al. in respect to our explanations of the different effects of somatostatin on gastrin and growth hormone gene expression. Baringa et al. studied the changes in growth hormone gene transcription only after brief exposure to somatostatin. By contrast, the present study examined somatostatin's effects on gastrin gene expression after treatment for longer periods. Furthermore, the present in vivo study cannot determine whether the change in gastrin mRNA levels results from a direct effect of somatostatin on G cells or if it is an indirect consequence of somatostatin inhibiting the release of G-cell stimuli (such as gastrin-releasing peptide) from mucosal nerve terminals. Further studies are therefore required to show whether somatostatin inhibits gastrin gene expression by a direct cellular action and to define the intracellular events that mediate somatostatin effects on gastrin gene expression.
